Drug target · GRM2
mGlu2
Metabotropic glutamate receptor 2
3 compounds in the CNS pipeline act on mGlu2.
Compounds targeting mGlu2
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| MK-1942primarySmall molecule | NAM | — | DiscontinuedTreatment-resistant depression | Merck & Co., Inc. |
| Pomaglumetad methionilprimarySmall molecule | Agonist | Ki 149 nM | DiscontinuedSchizophrenia | Eli Lilly and Company |
| TS-161primarySmall molecule | Antagonist | Ki 4.27 nM | DiscontinuedTreatment-resistant depression | Taisho Pharmaceutical Co., Ltd. |